BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T090000
DTEND;TZID=America/Vancouver:20221027T153000
DTSTAMP:20260820T014733
CREATED:20220922T175424Z
LAST-MODIFIED:20220922T175758Z
UID:19617-1666774800-1666884600@scienceinseattle.com
SUMMARY:BioBasics 101: The Biology of Biotech for the Non-Scientist
DESCRIPTION:BioBasics 101: The Biology of Biotech for the Non-Scientist is an intensive two-day course that explains the foundational science upon which all biopharma therapies are based. Day one focuses on the function of DNA\, RNA\, proteins\, and cell signaling and how each interacts in both healthy and diseased tissue. Day two builds on your newfound molecular biology knowledge. This includes a more in-depth look at genetic disease and how genetic engineering is used to create personalized medicine options for patients. The course ends with a survey of small molecule drugs\, biologics\, and vaccines and explains how each mitigates disease at the molecular level. BioBasics 101 will increase your scientific knowledge so that you can converse more effectively with colleagues\, clients\, regulators\, and scientists. \nBioBasics 101 was developed for the non-science professional who works within or services the biopharma industry. \nPlease note that all local COVID-19 mandates for onsite classes will be followed. Please contact us at info@biotechprimer.com if you would like clarification of the local rules. \nWho should attend\nNon-science professionals from all sectors including: finance\, legal\, sales\, marketing\, HR\, manufacturing\, management\, government relations\, IT\, project management\, regulatory affairs\, supply chain\, safety\, tech transfer. Anyone who works on the “business-side” who needs to better understand and communicate with the “science-side” \nPast participants include: \n\nVenture capitalists\, angel investors\, bankers\, analysts\, financial managers\nInsurance brokers\, real estate professionals\nPatient advocacy group staff\, disease foundation members\nPolicy makers\, lobbyists\, attorneys\nConsultants\, public relations specialists\, journalists\nUniversity administrators\, research institute support staff\nEnvironmental\, health and safety engineers\n\nPrice : Early bird member rate before August 1: $1245\nStandard Member Rate – $1495\nNon-Members – $1595
URL:https://scienceinseattle.com/event/biobasics-101-the-biology-of-biotech-for-the-non-scientist/
LOCATION:Life Science Washington Office
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2022/09/unnamed-6.png
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T090000
DTEND;TZID=America/Vancouver:20221027T153000
DTSTAMP:20260820T014733
CREATED:20220922T175424Z
LAST-MODIFIED:20220922T175424Z
UID:25939-1666774800-1666884600@scienceinseattle.com
SUMMARY:BioBasics 101: The Biology of Biotech for the Non-Scientist
DESCRIPTION:BioBasics 101: The Biology of Biotech for the Non-Scientist is an intensive two-day course that explains the foundational science upon which all biopharma therapies are based. Day one focuses on the function of DNA\, RNA\, proteins\, and cell signaling and how each interacts in both healthy and diseased tissue. Day two builds on your newfound molecular biology knowledge. This includes a more in-depth look at genetic disease and how genetic engineering is used to create personalized medicine options for patients. The course ends with a survey of small molecule drugs\, biologics\, and vaccines and explains how each mitigates disease at the molecular level. BioBasics 101 will increase your scientific knowledge so that you can converse more effectively with colleagues\, clients\, regulators\, and scientists. \nBioBasics 101 was developed for the non-science professional who works within or services the biopharma industry. \nPlease note that all local COVID-19 mandates for onsite classes will be followed. Please contact us at info@biotechprimer.com if you would like clarification of the local rules. \nWho should attend\nNon-science professionals from all sectors including: finance\, legal\, sales\, marketing\, HR\, manufacturing\, management\, government relations\, IT\, project management\, regulatory affairs\, supply chain\, safety\, tech transfer. Anyone who works on the “business-side” who needs to better understand and communicate with the “science-side” \nPast participants include: \n\nVenture capitalists\, angel investors\, bankers\, analysts\, financial managers\nInsurance brokers\, real estate professionals\nPatient advocacy group staff\, disease foundation members\nPolicy makers\, lobbyists\, attorneys\nConsultants\, public relations specialists\, journalists\nUniversity administrators\, research institute support staff\nEnvironmental\, health and safety engineers\n\nPrice : Early bird member rate before August 1: $1245\nStandard Member Rate – $1495\nNon-Members – $1595
URL:https://scienceinseattle.com/event/biobasics-101-the-biology-of-biotech-for-the-non-scientist-2/
LOCATION:Life Science Washington Office
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2022/09/unnamed-6.png
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T090000
DTEND;TZID=America/Vancouver:20221027T153000
DTSTAMP:20260820T014733
CREATED:20220922T175424Z
LAST-MODIFIED:20220922T175424Z
UID:26903-1666774800-1666884600@scienceinseattle.com
SUMMARY:BioBasics 101: The Biology of Biotech for the Non-Scientist
DESCRIPTION:BioBasics 101: The Biology of Biotech for the Non-Scientist is an intensive two-day course that explains the foundational science upon which all biopharma therapies are based. Day one focuses on the function of DNA\, RNA\, proteins\, and cell signaling and how each interacts in both healthy and diseased tissue. Day two builds on your newfound molecular biology knowledge. This includes a more in-depth look at genetic disease and how genetic engineering is used to create personalized medicine options for patients. The course ends with a survey of small molecule drugs\, biologics\, and vaccines and explains how each mitigates disease at the molecular level. BioBasics 101 will increase your scientific knowledge so that you can converse more effectively with colleagues\, clients\, regulators\, and scientists. \nBioBasics 101 was developed for the non-science professional who works within or services the biopharma industry. \nPlease note that all local COVID-19 mandates for onsite classes will be followed. Please contact us at info@biotechprimer.com if you would like clarification of the local rules. \nWho should attend\nNon-science professionals from all sectors including: finance\, legal\, sales\, marketing\, HR\, manufacturing\, management\, government relations\, IT\, project management\, regulatory affairs\, supply chain\, safety\, tech transfer. Anyone who works on the “business-side” who needs to better understand and communicate with the “science-side” \nPast participants include: \n\nVenture capitalists\, angel investors\, bankers\, analysts\, financial managers\nInsurance brokers\, real estate professionals\nPatient advocacy group staff\, disease foundation members\nPolicy makers\, lobbyists\, attorneys\nConsultants\, public relations specialists\, journalists\nUniversity administrators\, research institute support staff\nEnvironmental\, health and safety engineers\n\nPrice : Early bird member rate before August 1: $1245\nStandard Member Rate – $1495\nNon-Members – $1595
URL:https://scienceinseattle.com/event/biobasics-101-the-biology-of-biotech-for-the-non-scientist-3/
LOCATION:Life Science Washington Office
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2022/09/unnamed-6.png
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T103000
DTEND;TZID=America/Vancouver:20221026T113000
DTSTAMP:20260820T014733
CREATED:20220829T195950Z
LAST-MODIFIED:20220829T195950Z
UID:19277-1666780200-1666783800@scienceinseattle.com
SUMMARY:Distinguished Seminar Series - Brian Dias
DESCRIPTION:Understanding and breaking legacies of stress \n\n\nHistorical events have generated data indicating that stressors experienced by populations\, affect not only the individuals directly exposed to them\, but also descendants. My talk will shed light on the nature and mechanisms by which legacies of stress perpetuate across generations\, and how we may begin to break them. \nBrian Dias is an Assistant Professor in the Department of Pediatrics at the USC Keck School of Medicine and directs a research laboratory in the Developmental Neuroscience & Neurogenetics Program at The Saban Research Institute\, Children’s Hospital Los Angeles. Dr. Dias’ research seeks to understand how mammalian neurobiology\, physiology and reproductive biology is impacted by stress or trauma\, and how parental legacies of stress or trauma influence offspring. Armed with this understanding\, Dr. Dias and his team aim to inform therapeutic and policy interventions to ameliorate the effects of stress or trauma in both\, ancestral and descendant populations. Toward this goal\, Dr. Dias uses molecular\, cellular\, genetic\, epigenetic\, physiological\, and behavioral approaches to investigate how the biology of an organism and its responsiveness to stress or trauma is influenced by micro- (genome\, epigenome and hormones)\, and macro-environments (ancestral\, in utero and post-natal experiences). Among other outlets\, Dr. Dias’ work has been featured in Nature\, on the BBC\, and in a list of the 10 Most Important Discoveries of 2014 published by La Recherche Magazine. Most recently\, he was quoted about the legacy of trauma (BBC)\, the neurobiology of family separation (BrainFacts)\, and gave a TEDx talk on Halting Legacies of Trauma. In 2017\, Dr. Dias was awarded a CIFAR Azrieli Global Scholar Award (competitive awards given to exceptional early career investigators from around the world by the Canadian Institute for Advanced Research (CIFAR)\, and is currently a Fellow in CIFAR’s Child & Brain Development Program. In 2019\, Dr. Dias was selected to be part of the Young Leader network at the Science & Technology in Society Forum in Kyoto\, Japan (an invitation-only forum that includes world leaders and diplomats discussing how science and technology can address roadblocks to human progress). In addition to his research\, Dr. Dias is interested in education and knowledge mobilization. This interest has seen Dr. Dias participate in Sci-Foo Camp at Google – an invitation-only ideas festival that is often described as a mini-Woodstock of ideas. Dr. Dias is a faculty member of the Emory Tibet Science Initiative\, teaches Neuroscience to Tibetan Buddhist monastics\, and participated on a panel discussing “Consciousness” with scholars that included the Dalai Lama. More information is available at his lab website.
URL:https://scienceinseattle.com/event/distinguished-seminar-series-brian-dias/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T103000
DTEND;TZID=America/Vancouver:20221026T113000
DTSTAMP:20260820T014733
CREATED:20220829T195950Z
LAST-MODIFIED:20220829T195950Z
UID:25931-1666780200-1666783800@scienceinseattle.com
SUMMARY:Distinguished Seminar Series - Brian Dias
DESCRIPTION:Understanding and breaking legacies of stress \n\n\nHistorical events have generated data indicating that stressors experienced by populations\, affect not only the individuals directly exposed to them\, but also descendants. My talk will shed light on the nature and mechanisms by which legacies of stress perpetuate across generations\, and how we may begin to break them. \nBrian Dias is an Assistant Professor in the Department of Pediatrics at the USC Keck School of Medicine and directs a research laboratory in the Developmental Neuroscience & Neurogenetics Program at The Saban Research Institute\, Children’s Hospital Los Angeles. Dr. Dias’ research seeks to understand how mammalian neurobiology\, physiology and reproductive biology is impacted by stress or trauma\, and how parental legacies of stress or trauma influence offspring. Armed with this understanding\, Dr. Dias and his team aim to inform therapeutic and policy interventions to ameliorate the effects of stress or trauma in both\, ancestral and descendant populations. Toward this goal\, Dr. Dias uses molecular\, cellular\, genetic\, epigenetic\, physiological\, and behavioral approaches to investigate how the biology of an organism and its responsiveness to stress or trauma is influenced by micro- (genome\, epigenome and hormones)\, and macro-environments (ancestral\, in utero and post-natal experiences). Among other outlets\, Dr. Dias’ work has been featured in Nature\, on the BBC\, and in a list of the 10 Most Important Discoveries of 2014 published by La Recherche Magazine. Most recently\, he was quoted about the legacy of trauma (BBC)\, the neurobiology of family separation (BrainFacts)\, and gave a TEDx talk on Halting Legacies of Trauma. In 2017\, Dr. Dias was awarded a CIFAR Azrieli Global Scholar Award (competitive awards given to exceptional early career investigators from around the world by the Canadian Institute for Advanced Research (CIFAR)\, and is currently a Fellow in CIFAR’s Child & Brain Development Program. In 2019\, Dr. Dias was selected to be part of the Young Leader network at the Science & Technology in Society Forum in Kyoto\, Japan (an invitation-only forum that includes world leaders and diplomats discussing how science and technology can address roadblocks to human progress). In addition to his research\, Dr. Dias is interested in education and knowledge mobilization. This interest has seen Dr. Dias participate in Sci-Foo Camp at Google – an invitation-only ideas festival that is often described as a mini-Woodstock of ideas. Dr. Dias is a faculty member of the Emory Tibet Science Initiative\, teaches Neuroscience to Tibetan Buddhist monastics\, and participated on a panel discussing “Consciousness” with scholars that included the Dalai Lama. More information is available at his lab website.
URL:https://scienceinseattle.com/event/distinguished-seminar-series-brian-dias-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T103000
DTEND;TZID=America/Vancouver:20221026T113000
DTSTAMP:20260820T014733
CREATED:20220829T195950Z
LAST-MODIFIED:20220829T195950Z
UID:26895-1666780200-1666783800@scienceinseattle.com
SUMMARY:Distinguished Seminar Series - Brian Dias
DESCRIPTION:Understanding and breaking legacies of stress \n\n\nHistorical events have generated data indicating that stressors experienced by populations\, affect not only the individuals directly exposed to them\, but also descendants. My talk will shed light on the nature and mechanisms by which legacies of stress perpetuate across generations\, and how we may begin to break them. \nBrian Dias is an Assistant Professor in the Department of Pediatrics at the USC Keck School of Medicine and directs a research laboratory in the Developmental Neuroscience & Neurogenetics Program at The Saban Research Institute\, Children’s Hospital Los Angeles. Dr. Dias’ research seeks to understand how mammalian neurobiology\, physiology and reproductive biology is impacted by stress or trauma\, and how parental legacies of stress or trauma influence offspring. Armed with this understanding\, Dr. Dias and his team aim to inform therapeutic and policy interventions to ameliorate the effects of stress or trauma in both\, ancestral and descendant populations. Toward this goal\, Dr. Dias uses molecular\, cellular\, genetic\, epigenetic\, physiological\, and behavioral approaches to investigate how the biology of an organism and its responsiveness to stress or trauma is influenced by micro- (genome\, epigenome and hormones)\, and macro-environments (ancestral\, in utero and post-natal experiences). Among other outlets\, Dr. Dias’ work has been featured in Nature\, on the BBC\, and in a list of the 10 Most Important Discoveries of 2014 published by La Recherche Magazine. Most recently\, he was quoted about the legacy of trauma (BBC)\, the neurobiology of family separation (BrainFacts)\, and gave a TEDx talk on Halting Legacies of Trauma. In 2017\, Dr. Dias was awarded a CIFAR Azrieli Global Scholar Award (competitive awards given to exceptional early career investigators from around the world by the Canadian Institute for Advanced Research (CIFAR)\, and is currently a Fellow in CIFAR’s Child & Brain Development Program. In 2019\, Dr. Dias was selected to be part of the Young Leader network at the Science & Technology in Society Forum in Kyoto\, Japan (an invitation-only forum that includes world leaders and diplomats discussing how science and technology can address roadblocks to human progress). In addition to his research\, Dr. Dias is interested in education and knowledge mobilization. This interest has seen Dr. Dias participate in Sci-Foo Camp at Google – an invitation-only ideas festival that is often described as a mini-Woodstock of ideas. Dr. Dias is a faculty member of the Emory Tibet Science Initiative\, teaches Neuroscience to Tibetan Buddhist monastics\, and participated on a panel discussing “Consciousness” with scholars that included the Dalai Lama. More information is available at his lab website.
URL:https://scienceinseattle.com/event/distinguished-seminar-series-brian-dias-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T193000
DTEND;TZID=America/Vancouver:20221026T203000
DTSTAMP:20260820T014733
CREATED:20221012T161209Z
LAST-MODIFIED:20221012T161209Z
UID:19849-1666812600-1666816200@scienceinseattle.com
SUMMARY:Engineering Therapies for the Pediatric Brain
DESCRIPTION:Children make up 27% of the world’s population\, but most therapeutics for brain disease are tested on adults with pediatric clinical trials often following years later. This has led to a significant gap in medical technology for infants and children. UW chemical engineering associate professor Elizabeth Nance is developing therapeutics for newborn and pediatric brain disease\, with the goal of improving neurological function and quality of life. Learn more about Nance’s work to expand brain health options through these early stages of life. \nElizabeth Nance is the Jagjeet and Janice Bindra Endowed Career Development Associate Professor of Chemical Engineering\, with appointments in bioengineering and radiology\, and affiliate memberships with the eScience Institute\, Molecular Engineering & Sciences Institute\, and Center on Human Development and Disability. Nance’s research focuses on understanding the brain’s response to injury or disease and developing nanotherapeutic platforms to treat brain disease\, using nanotechnology\, neurobiology\, and data science tools.
URL:https://scienceinseattle.com/event/engineering-therapies-for-the-pediatric-brain/
LOCATION:Kane Hall 130
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T193000
DTEND;TZID=America/Vancouver:20221026T203000
DTSTAMP:20260820T014733
CREATED:20221012T161209Z
LAST-MODIFIED:20221012T161209Z
UID:25941-1666812600-1666816200@scienceinseattle.com
SUMMARY:Engineering Therapies for the Pediatric Brain
DESCRIPTION:Children make up 27% of the world’s population\, but most therapeutics for brain disease are tested on adults with pediatric clinical trials often following years later. This has led to a significant gap in medical technology for infants and children. UW chemical engineering associate professor Elizabeth Nance is developing therapeutics for newborn and pediatric brain disease\, with the goal of improving neurological function and quality of life. Learn more about Nance’s work to expand brain health options through these early stages of life. \nElizabeth Nance is the Jagjeet and Janice Bindra Endowed Career Development Associate Professor of Chemical Engineering\, with appointments in bioengineering and radiology\, and affiliate memberships with the eScience Institute\, Molecular Engineering & Sciences Institute\, and Center on Human Development and Disability. Nance’s research focuses on understanding the brain’s response to injury or disease and developing nanotherapeutic platforms to treat brain disease\, using nanotechnology\, neurobiology\, and data science tools.
URL:https://scienceinseattle.com/event/engineering-therapies-for-the-pediatric-brain-2/
LOCATION:Kane Hall 130
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T193000
DTEND;TZID=America/Vancouver:20221026T203000
DTSTAMP:20260820T014733
CREATED:20221012T161209Z
LAST-MODIFIED:20221012T161209Z
UID:26905-1666812600-1666816200@scienceinseattle.com
SUMMARY:Engineering Therapies for the Pediatric Brain
DESCRIPTION:Children make up 27% of the world’s population\, but most therapeutics for brain disease are tested on adults with pediatric clinical trials often following years later. This has led to a significant gap in medical technology for infants and children. UW chemical engineering associate professor Elizabeth Nance is developing therapeutics for newborn and pediatric brain disease\, with the goal of improving neurological function and quality of life. Learn more about Nance’s work to expand brain health options through these early stages of life. \nElizabeth Nance is the Jagjeet and Janice Bindra Endowed Career Development Associate Professor of Chemical Engineering\, with appointments in bioengineering and radiology\, and affiliate memberships with the eScience Institute\, Molecular Engineering & Sciences Institute\, and Center on Human Development and Disability. Nance’s research focuses on understanding the brain’s response to injury or disease and developing nanotherapeutic platforms to treat brain disease\, using nanotechnology\, neurobiology\, and data science tools.
URL:https://scienceinseattle.com/event/engineering-therapies-for-the-pediatric-brain-3/
LOCATION:Kane Hall 130
END:VEVENT
END:VCALENDAR